PMC:7264098 / 3704-3914 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T91","span":{"begin":38,"end":48},"obj":"SP_7"},{"id":"T92","span":{"begin":58,"end":63},"obj":"SP_6;NCBITaxon:9606"},{"id":"T93","span":{"begin":64,"end":77},"obj":"PR:000036008"},{"id":"T94","span":{"begin":99,"end":103},"obj":"PR:000003622;G_3;PG_10"},{"id":"T95","span":{"begin":118,"end":128},"obj":"GO:0035376"},{"id":"T96","span":{"begin":183,"end":188},"obj":"SP_6;NCBITaxon:9606"},{"id":"T97","span":{"begin":192,"end":197},"obj":"SP_6;NCBITaxon:9606"},{"id":"T61458","span":{"begin":38,"end":48},"obj":"SP_7"},{"id":"T705","span":{"begin":58,"end":63},"obj":"SP_6;NCBITaxon:9606"},{"id":"T20113","span":{"begin":64,"end":77},"obj":"PR:000036008"},{"id":"T25995","span":{"begin":99,"end":103},"obj":"PR:000003622;G_3;PG_10"},{"id":"T34070","span":{"begin":118,"end":128},"obj":"GO:0035376"},{"id":"T67183","span":{"begin":183,"end":188},"obj":"SP_6;NCBITaxon:9606"},{"id":"T16190","span":{"begin":192,"end":197},"obj":"SP_6;NCBITaxon:9606"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"78","span":{"begin":64,"end":97},"obj":"Gene"},{"id":"79","span":{"begin":99,"end":103},"obj":"Gene"},{"id":"86","span":{"begin":38,"end":48},"obj":"Species"},{"id":"87","span":{"begin":58,"end":63},"obj":"Species"},{"id":"88","span":{"begin":183,"end":188},"obj":"Species"},{"id":"89","span":{"begin":192,"end":197},"obj":"Species"}],"attributes":[{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"Gene:59272"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Gene:59272"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"Tax:2697049"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"Tax:9606"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"Tax:9606"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":118,"end":122},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"T27","span":{"begin":38,"end":42},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T48","span":{"begin":118,"end":122},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T49","span":{"begin":183,"end":188},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T50","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":4,"end":8},"obj":"Chemical"},{"id":"T14","span":{"begin":64,"end":75},"obj":"Chemical"},{"id":"T15","span":{"begin":130,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_33382"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    2_test

    {"project":"2_test","denotations":[{"id":"32574317-32015508-31466289","span":{"begin":31,"end":35},"obj":"32015508"},{"id":"32574317-32007145-31466290","span":{"begin":141,"end":145},"obj":"32007145"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}

    MyTest

    {"project":"MyTest","denotations":[{"id":"32574317-32015508-31466289","span":{"begin":31,"end":35},"obj":"32015508"},{"id":"32574317-32007145-31466290","span":{"begin":141,"end":145},"obj":"32007145"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"ino acid identity) (Wu et al., 2020). SARS-CoV-2 uses the human angiotensin I converting enzyme 2 (ACE2) receptor for cell entry (Lu et al., 2020), which could potentially facilitate human-to-human transmission"}